Showing results (161-170 of 177) with videos related to
Sort By:
Pageof 18
Seminars in Oncology|August 24, 1999
Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancerT Le Chevalier, J Bérille, J R Zalcberg, et al.Journal of the National Cancer Institute|February 22, 2001
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized studyJ L Pujol, J P Daurès, A Rivière, et al.La Nouvelle Presse Medicale|May 30, 1981
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)]J Rouesse, T Tursz, T Le Chevalier, et al.European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.Journal of the National Cancer Institute|December 18, 1996
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patientsT Tursz, A L Cesne, P Baldeyrou, et al.Bulletin Du Cancer|March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]T Le Chevalier, M Gottfried, U Gatzemeier, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patientsA Aupérin, C Le Péchoux, J P Pignon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III studyJ L Pujol, J Y Douillard, A Rivière, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2017
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancerM-S Tsao, G Le Teuff, F A Shepherd, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.Pageof 18